{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["b8f74cfd-e7d8-49fb-9161-1b4ac2cec663", "Q3", 4653, "ASSOCIATION OF NATIONAL ADVERTISERS, INC.", 104888, "ASSOCIATION OF NATIONAL ADVERTISERS, INC.", 2009, "third_quarter", "2009-10-20T12:06:20-04:00", 250000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/b8f74cfd-e7d8-49fb-9161-1b4ac2cec663/\", \"filing_uuid\": \"b8f74cfd-e7d8-49fb-9161-1b4ac2cec663\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2009, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/b8f74cfd-e7d8-49fb-9161-1b4ac2cec663/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"250000.00\", \"expenses_method\": \"c\", \"expenses_method_display\": \"Method C - Reporting amounts under section 162(e) of the Internal Revenue Code\", \"posted_by_name\": \"Daniel L. Jaffe, Executive Vice President, Government Relations\", \"dt_posted\": \"2009-10-20T12:06:20-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1120 20TH STREET, NW\", \"registrant_address_2\": \"Suite 520-South\", \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20036\", \"registrant\": {\"id\": 4653, \"url\": \"https://lda.senate.gov/api/v1/registrants/4653/\", \"house_registrant_id\": 30505, \"name\": \"ASSOCIATION OF NATIONAL ADVERTISERS, INC.\", \"description\": \"Trade association representing the advertising and marketing industry\", \"address_1\": \"2020 K STREET, NW\", \"address_2\": \"SUITE 660\", \"address_3\": null, \"address_4\": null, \"city\": \"WASHINGTON\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20006\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"CHRISTOPHER OSWALD\", \"contact_telephone\": \"+1 202-296-1883\", \"dt_updated\": \"2026-01-26T17:52:37.521236-05:00\"}, \"client\": {\"id\": 104888, \"url\": \"https://lda.senate.gov/api/v1/clients/104888/\", \"client_id\": 12, \"name\": \"ASSOCIATION OF NATIONAL ADVERTISERS, INC.\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2018-07-02\"}, \"lobbying_activities\": [{\"general_issue_code\": \"BEV\", \"general_issue_code_display\": \"Beverage Industry\", \"description\": \"Proposals to restrict the marketing of alcohol beverage products\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"FOO\", \"general_issue_code_display\": \"Food Industry (safety, labeling, etc.)\", \"description\": \"H.R. 1105 - Omnibus Appropriations Act, 2009, provision in the Financial Services report that requires a four-agency working group to study and develop recommendations for standards for the marketing of food when such marketing targets children who are 17 years old or younger or when such food represents a significant component of the diets of children\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Proposals to place a moratorium on prescription drug advertising and requiring a \\\"fair balance\\\" between risk and benefit information in prescription drug advertisements\\nProposals to extend FDA authority to over-the-counter drug advertisements H.R. 2175 - Familes for ED Decency Act, to prohibit the broadcast of drugs for erectile dysfuncton/male enhancement on indecency grounds\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CPI\", \"general_issue_code_display\": \"Computer Industry\", \"description\": \"S. 139 - Data Breach Notification Act, requiring notice to consumers when a security breach occurs\\nH.R. 2221 - Data Accountability and Trust Act, setting standards for consumer data security and notice requirements\\nFTC activity regarding development of self-regulatory principles for online behavioral advertising\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"COM\", \"general_issue_code_display\": \"Communications/Broadcasting/Radio/TV\", \"description\": \"H.R. 1084 - Commercial Advertisement Loudness Mitigation Act (CALM Act), to require the FCC to conduct a rulemaking regarding the volume of television commercials \\nFCC Notice of Inquiry on blocking technologies and content ratings for television commercials\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CSP\", \"general_issue_code_display\": \"Consumer Issues/Safety/Products\", \"description\": \"H.R. 3126 - proposal to create a Consumer Financial Protection Agency as they relate to the FTC and the advertising industry\\nProposals to reauthorize the Federal Trade Commission\\nFTC rulemaking making changes to guidelines on use of endorsements and testimonials in advertising\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TOB\", \"general_issue_code_display\": \"Tobacco\", \"description\": \"S. 579 - Federal Tobacco Act of 2009, provisions restricting advertising practices for tobacco products to limit youth exposure\\nH.R. 1256, S. 982 - Family Smoking Prevention and Tobacco Control Act, provisions transferring authority over tobacco advertising to FDA and requiring it to promulgate a rule to place limits on tobacco advertising H.R. 1261 - Youth Prevention and Tobacco Harm Reduction Act, provisions setting up a Tobacco Harm Reduction Center in the Department of Health and Human Services and setting up a commission to review and make recommendations to Congress on further advertising and marketing restrictions for tobacco products\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"H.R. 2917 - To amend the Internal Revenue Code of 1986 to deny any deduction for advertising prescription drugs\\nH.R. 2966 - Say No To Drug Ads Act, to prohibit the tax deduction for advertising of prescription drugs\\nProposals to fund health care reform by eliminating the tax deduction for advertisements of prescription drugs\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"Lobbying for increased funding for the Centers for Disease Control and Prevention's Division of Nutrition, Physical Activity and Obesity\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 40712, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIEL\", \"nickname\": null, \"middle_name\": \"L\", \"last_name\": \"JAFFE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42621, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"KEITH\", \"nickname\": null, \"middle_name\": \"A\", \"last_name\": \"SCARBOROUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 42623, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": \"P\", \"last_name\": \"BUZBY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 53, \"name\": \"Federal Communications Commission (FCC)\"}, {\"id\": 64, \"name\": \"Federal Trade Commission (FTC)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["b8f74cfd-e7d8-49fb-9161-1b4ac2cec663"], "units": {}, "query_ms": 0.9832410141825676, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}